WNT5A and melanoma: On the other hand, a protumorigenic role for Wnt5a has been shown for T-cell leukemia [17], melanoma [18], gastric cancer [19], non-small-cell lung cancer [20], pancreatic cancer [21], and prostate cancer [22].